| Mr Michael I Gabrilovich, MD | |
|
25 Office Park Dr, Hamilton, OH 45013-1496 | |
| (513) 893-5864 | |
| (513) 893-5865 |
| Full Name | Mr Michael I Gabrilovich |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 29 Years |
| Location | 25 Office Park Dr, Hamilton, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346322005 | NPI | - | NPPES |
| 2694722 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 35.085432 (Ohio) | Primary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 35.085432 (Ohio) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fort Hamilton Hughes Memorial Hospital | Hamilton, OH | Hospital |
| West Chester Hospital | West chester, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pulmonary, Critical Care And Sleep Medicine Associates, Llc | 1052318060 | 5 |
News Archive
Not surprisingly, a new study has shown that keeping active can keep the body young and healthy. The study comes from the researchers at the University of Birmingham and King's College London who were looking at the health of older adults who had been exercising most of their adult lives. The research has been reported in two papers published this week in the journal Aging Cell.
Researchers with the Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have secured $4 million in funding from the National Institutes of Health (NIH)/National Cancer Institute to establish an HIV-associated Malignancy Research Center (HAMRC) focused on lung cancer in East Africa.
SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ driver system, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart.
Intravenous immunoglobulin might offer a promising treatment for Alzheimer's disease, suggests preliminary research in the Journal of Neurology Neurosurgery and Psychiatry.
› Verified 3 days ago
| Entity Name | Mercy Health Physicians Cincinnati Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205887023 PECOS PAC ID: 6709790892 Enrollment ID: O20031113000395 |
News Archive
Not surprisingly, a new study has shown that keeping active can keep the body young and healthy. The study comes from the researchers at the University of Birmingham and King's College London who were looking at the health of older adults who had been exercising most of their adult lives. The research has been reported in two papers published this week in the journal Aging Cell.
Researchers with the Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have secured $4 million in funding from the National Institutes of Health (NIH)/National Cancer Institute to establish an HIV-associated Malignancy Research Center (HAMRC) focused on lung cancer in East Africa.
SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ driver system, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart.
Intravenous immunoglobulin might offer a promising treatment for Alzheimer's disease, suggests preliminary research in the Journal of Neurology Neurosurgery and Psychiatry.
› Verified 3 days ago
| Entity Name | Pulmonary, Critical Care And Sleep Medicine Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952407371 PECOS PAC ID: 1052318060 Enrollment ID: O20061106000353 |
News Archive
Not surprisingly, a new study has shown that keeping active can keep the body young and healthy. The study comes from the researchers at the University of Birmingham and King's College London who were looking at the health of older adults who had been exercising most of their adult lives. The research has been reported in two papers published this week in the journal Aging Cell.
Researchers with the Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have secured $4 million in funding from the National Institutes of Health (NIH)/National Cancer Institute to establish an HIV-associated Malignancy Research Center (HAMRC) focused on lung cancer in East Africa.
SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ driver system, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart.
Intravenous immunoglobulin might offer a promising treatment for Alzheimer's disease, suggests preliminary research in the Journal of Neurology Neurosurgery and Psychiatry.
› Verified 3 days ago
| Entity Name | Hospitalist Medicine Physicians Of Ohio, Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043572290 PECOS PAC ID: 3779749197 Enrollment ID: O20120730000162 |
News Archive
Not surprisingly, a new study has shown that keeping active can keep the body young and healthy. The study comes from the researchers at the University of Birmingham and King's College London who were looking at the health of older adults who had been exercising most of their adult lives. The research has been reported in two papers published this week in the journal Aging Cell.
Researchers with the Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have secured $4 million in funding from the National Institutes of Health (NIH)/National Cancer Institute to establish an HIV-associated Malignancy Research Center (HAMRC) focused on lung cancer in East Africa.
SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ driver system, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart.
Intravenous immunoglobulin might offer a promising treatment for Alzheimer's disease, suggests preliminary research in the Journal of Neurology Neurosurgery and Psychiatry.
› Verified 3 days ago
| Entity Name | Marion Area Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619230802 PECOS PAC ID: 1850549437 Enrollment ID: O20120925000053 |
News Archive
Not surprisingly, a new study has shown that keeping active can keep the body young and healthy. The study comes from the researchers at the University of Birmingham and King's College London who were looking at the health of older adults who had been exercising most of their adult lives. The research has been reported in two papers published this week in the journal Aging Cell.
Researchers with the Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have secured $4 million in funding from the National Institutes of Health (NIH)/National Cancer Institute to establish an HIV-associated Malignancy Research Center (HAMRC) focused on lung cancer in East Africa.
SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ driver system, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart.
Intravenous immunoglobulin might offer a promising treatment for Alzheimer's disease, suggests preliminary research in the Journal of Neurology Neurosurgery and Psychiatry.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Michael I Gabrilovich, MD 25 Office Park Dr, Hamilton, OH 45013-1496 Ph: (513) 893-5864 | Mr Michael I Gabrilovich, MD 25 Office Park Dr, Hamilton, OH 45013-1496 Ph: (513) 893-5864 |
News Archive
Not surprisingly, a new study has shown that keeping active can keep the body young and healthy. The study comes from the researchers at the University of Birmingham and King's College London who were looking at the health of older adults who had been exercising most of their adult lives. The research has been reported in two papers published this week in the journal Aging Cell.
Researchers with the Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have secured $4 million in funding from the National Institutes of Health (NIH)/National Cancer Institute to establish an HIV-associated Malignancy Research Center (HAMRC) focused on lung cancer in East Africa.
SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ driver system, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart.
Intravenous immunoglobulin might offer a promising treatment for Alzheimer's disease, suggests preliminary research in the Journal of Neurology Neurosurgery and Psychiatry.
› Verified 3 days ago
Dr. Arun Sendilnathan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1010 Cereal Ave Ste 300, Hamilton, OH 45013 Phone: 855-500-2873 Fax: 937-281-3913 | |
Mr. Thomas Vincent Sargero Jr., MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1010 Cereal Ave, Suite 305, Hamilton, OH 45013 Phone: 513-867-2811 Fax: 513-867-2094 | |
Joyce M Philip, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3035 Hamilton Mason Rd, Suite 203, Hamilton, OH 45011 Phone: 513-741-7200 Fax: 513-741-1977 | |
Theodore M Hunter, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 3145 Hamilton Mason Rd, 2nd Floor, Hamilton, OH 45011 Phone: 513-867-0015 Fax: 513-867-8751 | |
Dr. Howard L Bernie, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 520 Eaton Ave, Suite 100, Hamilton, OH 45013 Phone: 513-896-2200 Fax: 513-894-0096 | |
Dr. Ronald C. Schneider, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 610 High St, Hamilton, OH 45011 Phone: 513-981-4214 Fax: 513-981-4226 | |
Sucharitha Nalagatla, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2275 Millville Ave, Suite A, Hamilton, OH 45013 Phone: 513-892-3086 Fax: 513-892-3789 |